Edenred Shares Decline Despite Barclays' Target Increase to €22
Mid-afternoon on Wednesday, April 29, 2026, Edenred's stock price is at €21.19, down 2.26% from the previous day's close. This movement follows a target price increase by Barclays, even as the stock maintains a three-month gain of 22.34%. The annual general meeting is scheduled for next week, May 7.
Barclays Raises Target to €22, Limited Upside Potential
Barclays has increased its target price on Edenred from €21 to €22, accompanying the adjustment with a market-weight recommendation. Based on the current session price of €21.19, this new target offers a theoretical appreciation potential of about 3.8%. This revision follows a favorable stock market sequence for the professional payment solutions specialist, which saw a 4.3% increase on April 23 after the publication of its quarterly revenue, followed by a 2.7% increase the next session. The company's financial calendar is now focused on the upcoming 2026 general assembly scheduled for May 7.
Tense Technical Setup After Quarterly Rally
The decline observed in the session occurs in a context where several indicators signal an overbought configuration. The RSI is at 73, above the traditional threshold of 70 that marks a buyer tension zone. Concurrently, the price is at €21.19, which is 86% of the width of the Bollinger Bands ranging between €14.95 and €22.19, very close to the upper boundary. The stock also comes into contact with its identified technical resistance at €21.57. Over three months, Edenred maintains an advance of 22.34%, but remains down 18.56% over one year. The next notable date on the calendar is the general assembly on May 7, 2026.
